Hot Paths

Nektar gains 5% as jury awards $90M plus interest in Lilly trial (NKTR:NASDAQ)

Press Room
Modern lab, test center or chemistry laboratory with scientific microscope, tubes and equipment at a desk for analysis, experiments and clinical trials. Copy space in an empty forensic research room

Charday Penn

  • Nektar Therapeutics (NKTR) on Friday said that a U.S. jury found Eli Lilly (LLY) liable for breaching an implied covenant of good faith and fair dealing in a dispute over their former collaboration on rezpegaldesleukin, awarding Nektar $90M in
Exit mobile version